Quantcast
Last updated on April 24, 2014 at 5:30 EDT

Latest Bleeding Stories

2014-01-27 23:01:00

The Firm is investigating Pradaxa lawsuits on behalf of individuals who suffered internal bleeding, including cerebral and gastrointestinal hemorrhage, allegedly due to Pradaxa. New York, NY (PRWEB) January 27, 2014 Thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) that allege the blood thinners caused patients to suffer serious, and even deadly, episodes of internal bleeding, are moving forward in U.S. District Court, Southern District of Illinois, Bernstein Liebhard...

2014-01-10 23:03:17

A daily low-dose aspirin can help stave off heart attacks and certain clot-caused strokes. But fewer than half of the people who could benefit from this drug take it, while many others take it when they shouldn't. Boston, MA (PRWEB) January 10, 2014 Aspirin is often hailed as a wonder drug, thanks to its ability to help stave off heart attacks and clot-caused strokes. But fewer than half of people who could benefit from a daily low-dose aspirin take it, while many others take it when...

2014-01-08 23:27:53

Conquer Low Platelets designed by Louis Cruz is the latest program that teaches people how to prevent or treat thrombocytopenia related diseases and conditions. Is the Conquer Low Platelets review on the website Vinamy.com trustworthy? Seattle, WA (PRWEB) January 08, 2014 Conquer Low Platelets is the latest program that teaches people how to avoid sudden bleeding, harsh steroids, and low platelets. The program also provides people with natural and safe remedies for preventing or treating...

2014-01-06 23:02:11

The Firm is evaluating Pradaxa lawsuits on behalf of individuals who suffered serious occurrences of internal bleeding, allegedly due to their use of the blood thinner. New York, New York (PRWEB) January 06, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to move forward in courts around the country, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) is planning a large scale assessment of Pradaxa bleeding rates. In a posting on an...

2014-01-06 08:27:55

- Company specializing in hemostatic agents will provide QuikClot family of products under new contract - WALLINGFORD, Conn., Jan. 6, 2014 /PRNewswire/ -- Z-Medica, a leading developer and marketer of hemostatic agents, announced it has signed an agreement with HealthTrust, a group purchasing and total cost management solutions company, to provide its healthcare member facilities access to QuikClot(®) products under a vascular closure patch category, effective January 1, 2014....

2013-12-23 16:23:07

PLAINSBORO, N.J., Dec. 23, 2013 /PRNewswire/ -- Novo Nordisk today announced the US Food and Drug Administration (FDA) has approved TRETTEN(®) (Coagulation Factor XIII A-Subunit [Recombinant]) for the routine prophylaxis of bleeding in people with congenital factor XIII (FXIII) A-subunit deficiency, a serious, rare bleeding disorder with limited treatment options. TRETTEN(®) is the only recombinant treatment for congenital FXIII A-subunit deficiency. TRETTEN(®) was proven safe and...

2013-12-03 16:25:03

XARELTO® is the Most Prescribed Novel Oral Anticoagulant in the U.S. Market Today RARITAN, N.J., Dec. 3, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that new data involving its novel oral anticoagulant XARELTO(®) (rivaroxaban) will be presented at the 55(th) American Society of Hematology (ASH) Annual Meeting and Exposition held in New Orleans, LA, USA, from December 7-10, 2013. Notable presentations at ASH's Annual Meeting and Exposition include:...

2013-11-19 12:10:08

Abstract 17765 (Room C140) For the first time, an antidote developed specifically for dabigatran successfully reversed the effects of the anti-clotting medication in healthy volunteers, according to research presented at the American Heart Association's Scientific Sessions 2013. New oral anti-clotting medications such as dabigatran (Pradaxa) are easier to take than warfarin. However, up until now, there have been no specific antidotes available to reverse the effects of these new...

2013-11-13 23:27:31

As The Courts Continue To Receive Pradaxa Lawsuits, Wright & Schulte LLC Files A Pradaxa Internal Bleeding Lawsuit Aleging A Woman’s Wrongful Death Was From a Gastrointestinal Hemorrhage Due To Pradaxa Columbus, OH (PRWEB) November 13, 2013 As The Courts Continue To Receive Pradaxa Lawsuits, Wright & Schulte LLC Files A Pradaxa Internal Bleeding Lawsuit Aleging A Woman’s Wrongful Death Was From a Gastrointestinal Hemorrhage Due To Pradaxa Pradaxa internal bleeding lawsuits...

2013-11-13 12:27:00

DEERFIELD, Ill., Nov. 13, 2013 /PRNewswire/ -- Baxter International Inc. today announced it has completed enrollment in its Phase III clinical trial of BAX 855, an investigational extended half-life, recombinant factor VIII (rFVIII) treatment for hemophilia A. The ongoing trial is aimed at assessing the efficacy of the compound in reducing annualized bleed rates (ABR) in both prophylaxis and on-demand treatment schedules, and will also evaluate its safety and pharmacokinetic profile....